kd7040
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2007 (NCT00576108)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Nitric-oxide synthase, brainINHIBITOR
NOS1 inhibitor
- Nitric oxide synthase, inducibleINHIBITOR
Nitric oxide synthase, inducible inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CN(CCCNCc1ccc2c(c1)OCO2)c1nc(-n2ccnc2)ns1- Mol. weight
- 372.45 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1911882 ↗
Also known as
- kd7040
- kd7040
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00576108 | Phase 2 | Nov 1, 2007 | Kalypsys, Inc. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kalypsys, Inc. | For profit | 1 | 1 | 1 | 2007 |
1 organizations
Page 1 / 1